Clarus Lifesciences III L.P. 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-12 4:30 pm Sale |
2022-01-10 | 13D | ESSA Pharma Inc. EPIX |
Clarus Lifesciences III L.P. | 2,187,912 4.960% |
-1,291,202 (-37.11%) |
Filing |